人體組成分析儀市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

全球人體組成分析儀市場預計將從 2025 年的 7.3932 億美元成長到 2031 年的 11.9554 億美元，複合年成長率達 8.34%，實現了顯著成長。

這些醫療評估設備專為精確量化體脂含量、瘦肌肉量和內臟水分含量等生理指標而設計，主要採用生物電電阻分析和雙能量X光檢測法等先進技術。全球肥胖和代謝性疾病盛行率的不斷上升是推動該市場成長的主要因素，使得精準的監測工具對於有效的臨床干預和永續的健康管理至關重要。此外，老年人口的成長以及非臨床健康中心擴大採用專業健康監測方案，也進一步促進了對這些關鍵診斷系統的持續需求。然而，阻礙市場進一步擴張的一個重大挑戰是商用級設備所需的大量資金投入。這一經濟障礙限制了資源有限的醫療機構和小規模診所採用這些設備。儘管如此，該市場仍具有巨大的潛力。世界肥胖聯盟在2025年預測中指出，到2030年，全球成年肥胖人口將達到11.3億。這項預測表明，體成分分析的目標市場將大幅擴張，凸顯了迫切需要準確的診斷解決方案來有效應對與體重相關的公共衛生問題。

市場促進因素

全球肥胖和代謝性疾病盛行率的不斷上升是推動醫療保健和臨床機構擴大採用人體組成分析儀的主要動力。醫療專業人員正逐步從基本的體重測量轉向全面的人體組成分析，以便更準確地診斷和管理第2型糖尿病和心血管疾病等疾病。這種關鍵的臨床模式轉移凸顯了介入的緊迫性。根據世界肥胖聯盟於2025年3月發布的《2025年世界肥胖地圖集》報告，超重和肥胖每年導致160萬人死於非傳染性疾病。因此，醫院和專科診所正在大力投資高精度分析儀，以密切監測內臟脂肪和肌肉量，從而為高風險患者群體制定更有針對性的治療策略。同時，健身、健康俱樂部和健康中心產業的快速發展也顯著推動了市場擴張，因為這些機構透過採用專業級診斷設備來提升服務差異化。健身房和復健中心現在正利用這些設備為會員提供具體的指標，例如肌肉量增加和體脂減少，從而直接提高會員留存率和會員對其服務的感知價值。 Planet Fitness公司於2025年11月發布的2025年第三季財報反映了市場對需要此類設備的健身服務的強勁需求，該財報顯示其總收入成長了13.0%，達到3.303億美元。此外，消費者對體能監測的關注度也不斷提升。 Garmin公司報告稱，其健身部門在2025年第三季的銷售額成長了30%，這顯示消費者對個人體能監測技術的需求正在成長。

市場挑戰

限制市場擴張的一大因素是專業級人體組成分析儀所需的大量資本投入，這尤其影響到個人執業者和地方診所。這些先進的診斷系統需要大量的預付費用，對於預算緊張的小規模醫療機構而言，這些成本往往超過了即時經濟效益。因此，資源有限的醫療機構通常會優先考慮必要的營運支出，而不是採用先進的評估工具，這實際上將潛在客戶群限制在了資金雄厚的大規模機構。這種經濟障礙阻礙了此類儀器的廣泛應用，而這對於市場的強勁成長至關重要。美國醫院協會 (AHA) 在 2025 年的報告中進一步印證了這項挑戰：94% 的醫療機構管理者預計將因財務壓力而推遲設備升級。這項數據直接顯示了預算限制與延後資本設備採購之間的關聯。當醫療機構面臨財務不確定性時，採用人體組成分析儀等非緊急診斷技術往往是第一批被延遲的支出之一。這種不願投資新設備的做法導致銷售環境停滯不前，並直接阻礙了這些重要設備在全球醫療保健基礎設施中的廣泛應用。

市場趨勢

人工智慧 (AI) 在預測性健康分析中的應用正在從根本上改變市場，使設備從單純的測量工具轉變為精密的預測引擎。製造商正利用海量資料集訓練先進的演算法，這些演算法能夠識別細微的生理模式，從而在臨床症狀出現之前很久就能預測諸如肌肉減少症和內臟脂肪堆積等健康風險。這種創新能力有助於制定個人化的介入策略，並顯著提升這些系統在預防醫學領域的效用。例如，在 2024 年 2 月發布的《2024 年 InBody 報告》中，InBody 公司重點介紹了其如何利用其包含來自世界各地超過 1 億個身體組成數據點的雲資料庫，從中獲得新的醫學見解，包括識別區域性健康差異，例如瘦體重率。同時，攜帶式和家用診斷設備的普及正在使身體組成監測更加普及，從根本上將醫療保健的前沿陣地從傳統的醫院轉移到住宅環境。這一顯著趨勢的驅動力在於生物電電阻分析感測器的持續小型化，這些感測器正擴大整合到消費級智慧體重計和攜帶式監測器中，使用戶能夠持續了解自身的生理狀態。這個快速成長的消費市場正成為大型醫療設備製造商的重要收入來源。例如，Omron Corporation在其2024年9月發布的《2024年綜合報告》中指出，人體組成分析儀的銷售額佔其醫療保健業務部門總銷售額1,459億日圓的4%，證實了商業性對這些個人健康管理工具的強勁需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球人體組成分析儀市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（生物電電阻分析儀、皮下脂肪厚度測量儀、靜水壓體重測量儀、空氣置換體積描記法、雙能量X光吸收檢測法、其他）
  • 按最終用戶（醫院、健身俱樂部和健康中心中心、學術和研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美人體組成分析儀市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲人體組成分析儀市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區人體組成分析儀市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲人體成分分析儀市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲人體組成分析儀市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球人體組成分析儀市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Bodystat Ltd
• Cosmed SRL
• Hologic Inc.
• Inbody Co. Ltd
• Maltron International Ltd
• Omron Healthcare Inc.
• Seca GmbH & Co. Kg
• Tanita Corporation
• Fitbit Inc.
• Koninklijke Philips NV
• EatSmart Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Body Composition Analyzers Market is projected to expand significantly, growing from USD 739.32 Million in 2025 to USD 1195.54 Million by 2031, at an impressive Compound Annual Growth Rate (CAGR) of 8.34%. These medical assessment devices are specifically designed to precisely quantify physiological components like fat mass, lean muscle tissue, and visceral water content, primarily utilizing advanced techniques such as bioelectrical impedance analysis or dual-energy X-ray absorptiometry. This market's fundamental growth is propelled by the escalating global incidence of obesity and metabolic disorders, which critically demand accurate monitoring tools for effective clinical interventions and sustained health management. Additionally, the growing geriatric population and the increasing adoption of professional health monitoring protocols within non-clinical wellness centers further contribute to the sustained demand for these crucial diagnostic systems. One notable challenge impeding broader market expansion, however, is the substantial capital investment required for professional-grade devices. This financial barrier limits their adoption in healthcare settings with limited resources and smaller medical practices. Despite this, the market holds immense potential; the World Obesity Federation projected in 2025 that the global adult population living with obesity would reach 1.13 billion by 2030. This projection highlights a considerably expanding addressable market for body composition analysis, emphasizing the urgent need for precise diagnostic solutions to effectively manage weight-related public health concerns.

Market Driver

The rising global prevalence of obesity and metabolic disorders serves as a primary driver for the increased adoption of body composition analyzers in medical and clinical environments. Healthcare providers are progressively shifting from basic weight measurement to comprehensive body composition analysis to accurately diagnose and manage conditions such as type 2 diabetes and cardiovascular disease. This crucial clinical paradigm shift is underscored by the pressing need for intervention, as evidenced by the World Obesity Federation's 'World Obesity Atlas 2025' report from March 2025, which indicated that overweight and obesity annually contribute to 1.6 million premature deaths from non-communicable diseases. Consequently, hospitals and specialized clinics are making substantial investments in high-precision analyzers to meticulously monitor visceral fat and muscle mass, thereby enabling the development of more targeted therapeutic strategies for high-risk patient populations. Concurrently, the rapid growth of the fitness, health club, and wellness center industry is significantly bolstering market expansion, as these facilities differentiate their services through the integration of professional-grade diagnostics. Gyms and rehabilitation centers are now leveraging these devices to offer members tangible metrics on muscle gain and fat loss, which directly enhances member retention and the perceived value of their services. This robust commercial demand for fitness services necessitating such equipment is reflected in Planet Fitness, Inc.'s 'Third Quarter 2025 Results' from November 2025, reporting a 13.0% increase in total revenue to $330.3 million. Furthermore, a broader consumer trend toward performance monitoring is evident; Garmin Ltd. reported a 30% increase in revenue from its fitness segment in the third quarter of 2025, signaling a heightened consumer appetite for personal body monitoring technologies.

Market Challenge

A significant constraint on market expansion is the substantial capital investment required for professional-grade body composition analyzers, which particularly affects independent medical practices and community clinics. These advanced diagnostic systems entail considerable upfront costs that often surpass the immediate financial returns for smaller facilities operating with tight budgetary constraints. As a result, healthcare providers with limited resources frequently prioritize essential operational expenses over the acquisition of advanced assessment tools, effectively narrowing the potential customer base to larger, well-funded institutions. This economic impediment thus hinders the widespread adoption crucial for robust market growth. Further illustrating this challenge, the American Hospital Association reported in 2025 that 94% of healthcare administrators anticipated delaying equipment upgrades due to financial strain. This statistic directly demonstrates the correlation between budgetary pressures and the deferral of capital equipment purchases. When medical facilities face fiscal uncertainty, the procurement of non-emergency diagnostic technologies, such as body composition analyzers, is often among the first expenditures to be postponed. This reluctance to invest in new capital equipment creates a stagnant sales environment, directly impeding the broader integration of these essential devices into the global healthcare infrastructure.

Market Trends

The integration of Artificial Intelligence (AI) for Predictive Health Analytics is fundamentally transforming the market, evolving devices from mere measurement tools into sophisticated prognostic engines. Manufacturers are leveraging extensive datasets to train advanced algorithms capable of identifying subtle physiological patterns, thereby enabling the prediction of health risks like sarcopenia or visceral fat accumulation long before clinical symptoms become apparent. This innovative capability facilitates personalized intervention strategies, significantly enhancing the utility of these systems in the realm of preventive medicine. For instance, InBody Co., Ltd., in its '2024 InBody Report' from February 2024, highlighted how it utilized its cloud database, comprising over 100 million global body composition data points, to derive novel medical insights, including the identification of regional health disparities such as lean obesity rates. Concurrently, the proliferation of portable and home-use diagnostic devices is democratizing access to body composition monitoring, fundamentally shifting the primary point of care from traditional hospital settings to residential environments. This notable trend is fueled by the ongoing miniaturization of bioelectrical impedance analysis sensors, which are increasingly being integrated into consumer-grade smart scales and handheld monitors, providing users with continuous insight into their physiological status. This rapidly expanding consumer segment has emerged as a significant revenue stream for major medical device manufacturers. Omron Corporation, for example, noted in its 'Integrated Report 2024' from September 2024 that sales of body composition monitors accounted for 4% of its Healthcare Business division's total revenue of 145.9 billion yen, underscoring the strong commercial demand for these personal health management tools.

Key Market Players

• Bodystat Ltd
• Cosmed S.R.L
• Hologic Inc.
• Inbody Co. Ltd
• Maltron International Ltd
• Omron Healthcare Inc.
• Seca GmbH & Co. Kg
• Tanita Corporation
• Fitbit Inc.
• Koninklijke Philips NV
• EatSmart Inc.

Report Scope

In this report, the Global Body Composition Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Body Composition Analyzers Market, By Product

• Bio-impedance Analyzer
• Skinfold Callipers
• Hydrostatic Weighing Equipment
• Air Displacement Plethysmography
• Dual Energy X-ray Absorptiometry
• Other

Body Composition Analyzers Market, By End-User

• Hospitals
• Fitness Clubs and Wellness Centers
• Academic and Research Centers
• Other

Body Composition Analyzers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Body Composition Analyzers Market.

Available Customizations:

Global Body Composition Analyzers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Body Composition Analyzers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Bio-impedance Analyzer, Skinfold Callipers, Hydrostatic Weighing Equipment, Air Displacement Plethysmography, Dual Energy X-ray Absorptiometry, Other)
  • 5.2.2. By End-User (Hospitals, Fitness Clubs and Wellness Centers, Academic and Research Centers, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Body Composition Analyzers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Body Composition Analyzers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End-User
  • 6.3.2. Canada Body Composition Analyzers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End-User
  • 6.3.3. Mexico Body Composition Analyzers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End-User

7. Europe Body Composition Analyzers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Body Composition Analyzers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End-User
  • 7.3.2. France Body Composition Analyzers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End-User
  • 7.3.3. United Kingdom Body Composition Analyzers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Body Composition Analyzers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End-User
  • 7.3.5. Spain Body Composition Analyzers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End-User

8. Asia Pacific Body Composition Analyzers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Body Composition Analyzers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End-User
  • 8.3.2. India Body Composition Analyzers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End-User
  • 8.3.3. Japan Body Composition Analyzers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End-User
  • 8.3.4. South Korea Body Composition Analyzers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End-User
  • 8.3.5. Australia Body Composition Analyzers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End-User

9. Middle East & Africa Body Composition Analyzers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Body Composition Analyzers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End-User
  • 9.3.2. UAE Body Composition Analyzers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End-User
  • 9.3.3. South Africa Body Composition Analyzers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End-User

10. South America Body Composition Analyzers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Body Composition Analyzers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End-User
  • 10.3.2. Colombia Body Composition Analyzers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End-User
  • 10.3.3. Argentina Body Composition Analyzers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Body Composition Analyzers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bodystat Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cosmed S.R.L
• 15.3. Hologic Inc.
• 15.4. Inbody Co. Ltd
• 15.5. Maltron International Ltd
• 15.6. Omron Healthcare Inc.
• 15.7. Seca GmbH & Co. Kg
• 15.8. Tanita Corporation
• 15.9. Fitbit Inc.
• 15.10. Koninklijke Philips NV
• 15.11. EatSmart Inc.

16. Strategic Recommendations

17. About Us & Disclaimer